In this video, Ann Mullally, MD, discussed her presentation investigating the use of therapeutic antibodies to target mutant calreticulin in myeloproliferative neoplasms.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.